In addition, MLL-rearranged ALL is frequently associated with an overexpression of fms-related tyrosine kinase 3 (FLT3), that seems contributing, at least in part, to resistance to chemotherapy [26]. The gene discussed is FLT3; the disease is acute lymphoblastic leukemia.